What the hip preservation window means for patients

For many people with hip pain, the question that matters most is a practical one: is it too late for anything other than a replacement? The answer depends less on age or diagnosis alone than on where a patient sits within what clinicians call the hip preservation window — the period during which interventions that protect or restore the joint remain viable.

That window is not a fixed point. It narrows progressively as arthritis advances, shaped by three intersecting factors: how much cartilage has been lost, how old the patient is, and how physically demanding their daily life is. A person in their mid-forties with moderate joint damage and an active lifestyle occupies a very different position in that corridor than someone older with similar imaging findings and lower activity demands.

The clinical case for staying within the window rests partly on implant longevity. Approximately 58% of total hip replacements are estimated to last 25 years — a figure that carries real weight for patients in their forties or fifties, who might otherwise require one or more revision operations before the end of their active life.

Missing the preservation window does not represent a clinical setback. For some patients, the joint deteriorates to a point where replacement is simply the appropriate next step, and a structured pathway exists for that too. The sections that follow unpack each of the three variables — arthritis stage, age, and activity level — that determine how much of the window remains open.

How arthritis stage sets the outer boundary

Arthritis stage is the single most important structural variable in any preservation decision. In practical terms, this maps onto two different clinical pictures: a hip with partial cartilage loss — areas of thinning or focal damage where the underlying subchondral bone remains largely intact — and a hip with diffuse, end-stage wear, sometimes described informally as bone-on-bone contact.

In the first picture, preservation remains realistic. Cartilage repair and joint-protecting interventions work precisely because there is still viable tissue and bone to support them. In the second, there is no cartilage substrate left to restore; surgery can only replace the joint, not preserve it.

Clinicians commonly use the Kellgren–Lawrence (KL) grading system to classify hip osteoarthritis on a scale from 0 (normal) to 4 (severe), based on plain X-ray features such as joint space narrowing and osteophyte formation. KL grading provides a useful shared reference point, but hard grade-based thresholds for when preservation becomes futile have not been definitively established in the evidence base. In clinical practice, KL grade is one input alongside symptoms, functional demands, and MRI findings — not a single decision trigger.

Structural factors can accelerate deterioration independently of a patient's age. Femoroacetabular impingement (FAI) — abnormal bony contact within the hip joint caused by structural irregularities of the femoral head or acetabulum — is a recognised precursor to early hip osteoarthritis. Acetabular dysplasia and acetabular labral tears carry a similar risk. In younger patients, these mechanical drivers can shorten the preservation window considerably, even when overall cartilage loss still appears modest on imaging.

When damage is diffuse and symptoms are severe despite non-surgical management, cartilage repair is no longer a viable option. At that point, hip replacement is not a last resort — it is the appropriate and positive next step, and a clear pathway exists for reaching it.

Why age matters — but does not decide alone

The implant-longevity gap — already noted above — is what makes age clinically relevant in the first place: not youth itself, but the number of years a prosthesis must perform. For a patient in their mid-forties, that arithmetic points firmly toward exhausting preservation options before committing to a replacement.

That framing has led some clinicians to describe a rough preference for preservation in patients below around fifty. It is a useful shorthand, but it is convention rather than a hard evidence-based cut-off, and it can mislead if taken at face value.

The more revealing comparison is this: a fit 62-year-old with a focal cartilage defect, intact joint mechanics, and good bone stock may well be a stronger preservation candidate than a 44-year-old whose hip shows diffuse loss across the entire cartilage surface. The younger patient's age does not help them here — the near-total loss of viable cartilage substrate is what closes the preservation window, whatever the birth year. Where nothing remains to restore, preservation techniques cannot offer what a replacement achieves.

Age, in short, raises the question of whether preserving the joint is worth the effort. Arthritis stage — as described in the previous section — is what answers it.

Activity level as asset and accelerator

Physical activity presents an unusual clinical paradox in hip preservation: the same quality that makes a patient a strong recovery candidate can also accelerate the damage that makes preservation necessary in the first place.

A Delphi study by Jackson et al. (BMJ Open, 2015) identified activity-related hip pain as a recognised risk factor for early hip osteoarthritis, reflecting what mechanical reasoning predicts: joints subjected to high, repetitive loading — through manual occupations, distance running, or competitive sport — may accumulate cartilage stress more rapidly than more sedentary hips. For younger, highly active patients, this can narrow the preservation window despite an otherwise favourable structural profile.

That same activity level, however, brings real advantages when preservation remains viable. Active patients often arrive with stronger peri-articular musculature, physiotherapy familiarity, and the motivation to sustain intensive rehabilitation — qualities that matter considerably when recovery from a cartilage procedure depends substantially on patient commitment. Candidacy for procedures such as cartilage repair is assessed partly on activity level precisely because it shapes both the injury pattern and the recovery trajectory. When arthritis stage permits, fitness is a resource rather than a liability; the demanding use these patients place on their hips over decades is also why extending the preservation window matters so particularly for them.

Sedentary patients present a different challenge. Some arrive at first assessment with more advanced degenerative change, having tolerated worsening symptoms rather than sought early review. That is a clinical variable rather than a judgement, but it does affect how much of the preservation window remains when intervention finally begins.

What hip preservation actually involves

Hip preservation is not a single intervention but a layered pathway, broadly following four stages: symptom management, biologic and injection support, cartilage restoration, and — when those options are exhausted — joint replacement.

NICE guideline NG226 and NHS guidance establish the first principle clearly: conservative measures must be trialled before any surgical referral. That means physiotherapy to strengthen the peri-articular musculature, appropriate analgesia, and where relevant weight management to reduce joint load. These are not preliminary formalities — for patients at early stages, sustained exercise therapy can materially slow symptom progression and preserve the window for further intervention.

Intra-articular injections occupy the second stage and function as active clinical tools rather than stopgap palliation. Corticosteroid, hyaluronic acid (viscosupplementation), and PRP-class agents each have randomised trial support in hip osteoarthritis; the appropriate choice depends on the patient's symptom pattern, cartilage grade, and overall clinical picture. In practical terms, injections can reduce pain and inflammation sufficiently to allow structured physiotherapy that would otherwise be too uncomfortable — supporting the first stage rather than supplanting it.

For patients with a focal cartilage defect that has not progressed to diffuse, joint-wide loss, cartilage restoration options become relevant. ChondroFiller injection — an ultrasound-guided outpatient injectable collagen scaffold — works through matrix-induced chondrogenesis: placed into the defect under image guidance, the acellular scaffold recruits the patient's own progenitor cells to build repair tissue in situ. Surgical restoration options include AMIC (matrix-augmented microfracture, single-stage) and OATS (osteochondral autograft transfer), selected according to defect size, grade, and location.

Where a structural mechanical problem such as FAI or a labral tear is driving progressive cartilage damage, addressing that trigger surgically can extend the preservation window beyond what injection or scaffold repair alone achieves — particularly when performed before osteoarthritis becomes diffuse across the joint.

Determining which stage applies to a given patient requires clinical assessment that weighs arthritis severity, defect characteristics, activity demands, and bone quality together; no standard algorithm substitutes for that evaluation.

When the window has closed: hip replacement done well

Reaching the end of the preservation window is a clinical milestone, not a defeat. Joint replacement is indicated when pain and dysfunction persist despite conservative measures, injections, and preservation procedures — and arriving at that point reflects appropriate, stepwise care rather than any missed opportunity.

For patients at this stage, the SPAIRE technique — Save Piriformis And Internus, Repair Externus — offers a meaningful distinction from conventional posterior hip replacement. Rather than detaching and reattaching the small external rotator tendons at the back of the hip, SPAIRE keeps them intact throughout the operation. That soft-tissue preservation supports natural joint stability and may reduce dislocation risk during early recovery — a particular advantage for patients who have been actively managing their hip for some time and arrive at surgery with established movement patterns and rehabilitation experience. Professor Paul Lee trained in the SPAIRE approach at the Exeter Hip Unit under Professor Timperley, and performs it at Weymouth Street Hospital in London for Lincolnshire Hip patients.

Lincolnshire Hip is part of the MSK Doctors group and accepts patients without a GP referral for hip assessment, including assessment of whether replacement and the SPAIRE approach are the appropriate next step. For those who have reached that point, the technique offers a considered surgical endpoint — one that respects the soft tissue the joint has relied on throughout whatever preservation journey preceded it.

1. [1] Hip replacement. https://en.wikipedia.org/?curid=1125423 https://en.wikipedia.org/?curid=1125423
2. [2] Osteoarthritis. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841
3. [3] Joint replacement. https://en.wikipedia.org/?curid=2867638 https://en.wikipedia.org/?curid=2867638